Bethesda, Md. - The Parenteral Drug Association (PDA) has confirmed three keynote speakers for the 2009 PDA/FDA Joint Regulatory Conference who will discuss what the year 2020 will look like for the industry and what challenges must be overcome for the pharmaceutical industry, especially in the manufacturing segment of the industry.
Michael Bonney, President and CEO, Cubist Pharmaceuticals, Jacqueline Scott, Professor Harrison Institute for Public Law, Georgetown University, and Barbara Ryan, Analyst, Deutsche Bank will get the meeting started with their expert opinions on where they expect the industry to be in 2020. Specifically, Scott will be presenting about views on public policy as it pertains to 2020; and, Ryan will be speaking about the financial analyst perspective on the pharmaceutical industry.
From September 14 -16, hear directly from FDA experts and representatives of global regulatory authorities, and take home best practices for compliance. Each year at this PDA signature conference, FDA speakers provide updates on the development of global regulatory strategies; while industry professionals from some of today’s leading pharmaceutical companies present case studies on how they employ global strategies in their daily processes.
To learn more about the conference, visit www.pda.org/pdafda2009
About PDA - Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.